Denmark· DK-28106317819
Nucala
A mepolizumab product containing mepolizumab, registered in Denmark by GlaxoSmithKline Trading Services. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mepolizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC R03DX09 (mepolizumab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Mepolizumab · ATC R03DX09
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Mepolizumab
- Manufacturer
- GlaxoSmithKline Trading Services
- Country
- Denmark (DK)
- ATC code
- R03DX09
- ATC class
- Mepolizumab
- Defined daily dose
- 3.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106317819
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R03DX09
Mepolizumab, as other registers publish it.
- FinlandNucalaOrifarm Oy
- NorwayNucalaGlaxoSmithKline Trading Services Limited
- FinlandNucalaGlaxoSmithKline Trading Services Limited
- FinlandNucalaGlaxoSmithKline Trading Services Limited
- FinlandNucalaOrifarm Oy
- FinlandNucalaGlaxoSmithKline Trading Services Limited
- FinlandNucalaGlaxoSmithKline Trading Services Limited
- PolandNucalaGlaxoSmithKline Trading Services Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4fcdb57-404a-4471-a230-e82773a0b3c2 GET /v1/drugs/d4fcdb57-404a-4471-a230-e82773a0b3c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt pen",
"source": "dkma",
"strength": "100 mg",
"auth_role": "MOD",
"dk_drugid": "28106317819",
"substance": "Mepolizumab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43677"
}See everything about mepolizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.